{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T10:34:15Z","timestamp":1720089255875},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00393-006-0046-3","type":"journal-article","created":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T12:54:09Z","timestamp":1140699249000},"page":"110-123","source":"Crossref","is-referenced-by-count":1,"title":["Outcome-Parameter bei Psoriasisarthritis"],"prefix":"10.1007","volume":"65","author":[{"given":"J.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wassenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"Anderson","year":"2001","unstructured":"Anderson JJ, Baron G, Van der Heijde D, Felson DT, Dougados M (2001) Ankylosing Spondylitis Assessment Group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44: 1876\u20131886","journal-title":"Arthritis Rheum"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/art.10671","volume":"47","author":"Antoni","year":"2002","unstructured":"Antoni C, Dechant C, Lorenz HM et al. (2002) Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 47: 506\u2013512","journal-title":"Arthritis Rheum"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","volume":"52","author":"Antoni","year":"2005","unstructured":"Antoni CE, Kavanaugh A, Kirkham B et al. (2005) Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 52: 1227\u20131236","journal-title":"Arthritis Rheum"},{"key":"46_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association (1987) revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315\u2013324","journal-title":"Arthritis Rheum"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.20977","volume":"52","author":"Baraliakos","year":"2005","unstructured":"Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52: 1216\u20131223 [Epub ahead of print]","journal-title":"Arthritis Rheum"},{"key":"46_CR6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/ard.2004.031609","volume":"64","author":"Baraliakos","year":"2005","unstructured":"Baraliakos X, Herrmann KGA, Landewe R et al. (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging (MRI): a systematic comparison between contrast enhanced T1 and short-tau inversion recovery (STIR) sequences. Ann Rheum Dis 64: 1141\u20131144","journal-title":"Ann Rheum Dis"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"10","author":"Bland","year":"1986","unstructured":"Bland JM, Altman DD (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 10: 307\u2013310","journal-title":"Lancet"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","volume":"63","author":"Brandt","year":"2004","unstructured":"Brandt J, Listing J, Sieper J, Rudwaleit M, Van der Heijde D, Braun J (2004) Development and preselection of criteria for short-term improvement after anti-TNF\u03b1therapy in ankylosing spondylitis. Ann Rheum Dis 63:1438\u20131444","journal-title":"Ann Rheum Dis"},{"key":"46_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00063030-200317030-00005","volume":"17","author":"Braun","year":"2003","unstructured":"Braun J, Sieper J (2003) Role of novel biological therapies in psoriatic arthritis: effects on joints and skin. Biodrugs 17: 187\u2013199","journal-title":"Biodrugs"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","volume":"48","author":"Braun","year":"2003","unstructured":"Braun J, Baraliakos X, Golder W et al. (2003) MRI examinations of the spine in patients with ankylosing spondylitis (AS) before and after infliximab therapy after evaluation of a new scoring system. Arthritis Rheum 48: 1126\u20131136","journal-title":"Arthritis Rheum"},{"key":"46_CR11","doi-asserted-by":"crossref","unstructured":"Braun J, Davis J, Dougados M, Sieper J, Van der Linden S, Van der Heijde D (2005) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis [Epub ahead of print]","DOI":"10.1136\/ard.2005.040758"},{"key":"46_CR12","unstructured":"Bruce B, Fries JF (2005) The health assessment questionnaire (HAQ). Clin Exp Rheumatol [Suppl 39] 23: S14\u2013S18"},{"key":"46_CR13","first-page":"2281","volume":"21","author":"Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H et al. (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J Rheumatol 21: 2281\u20132285","journal-title":"J Rheumatol"},{"key":"46_CR14","first-page":"988","volume":"26","author":"Calin","year":"1999","unstructured":"Calin A, Mackay K, Santos H, Brophy S (1999) A new dimension to outcome: application of the Bath ankylosing spondylitis radiology index. J Rheumatol 26: 988\u2013992","journal-title":"J Rheumatol"},{"key":"46_CR15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","volume":"50","author":"Carlin","year":"2004","unstructured":"Carlin CS, Feldmann SR, Krueger JG, Menter A, Krueger GG (2004) A 50% reduction in the psoriasis area and severity index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol 50: 859\u2013866","journal-title":"J Am Acad Dermatol"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.1780391210","volume":"39","author":"Clegg","year":"1996","unstructured":"Clegg DO, Reda DJ, Mejias E et al. (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39: 2013\u20132020","journal-title":"Arthritis Rheum"},{"key":"46_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"Creemers","year":"2005","unstructured":"Creemers M, Franssen M, Van\u2019t Hof M, GribnauF, Van de Putte L, Van Riel P (2005) Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64: 127\u2013129","journal-title":"Ann Rheum Dis"},{"key":"46_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.10812","volume":"48","author":"D","year":"2003","unstructured":"D\u2019Agostino MA, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M (2003) Assesment of peripheral enthesitis in spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48: 523\u2013533","journal-title":"Arthritis Rheum"},{"key":"46_CR19","first-page":"946","volume":"17","author":"Daltroy","year":"1990","unstructured":"Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheumatol 17: 946\u2013950","journal-title":"J Rheumatol"},{"key":"46_CR20","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","volume":"48","author":"Davis","year":"2003","unstructured":"Davis JC Jr, Van Der Heijde D, Braun J et al. and the Enbrel Ankylosing Spondylitis Study Group (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48: 3230\u20133236","journal-title":"Arthritis Rheum"},{"key":"46_CR21","first-page":"993","volume":"26","author":"Dawes","year":"1999","unstructured":"Dawes PT (1999) Stoke ankylosing spondylitis spine score. J Rheumatol 26: 993\u2013996","journal-title":"J Rheumatol"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"Dougados","year":"1991","unstructured":"Dougados M, Van der Linden S, Juhlin R et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218\u20131227","journal-title":"Arthritis Rheum"},{"key":"46_CR23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M et al. (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38: 727\u2013735","journal-title":"Arthritis Rheum"},{"key":"46_CR24","first-page":"2286","volume":"21","author":"Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21: 2286\u20132291","journal-title":"J Rheumatol"},{"key":"46_CR25","doi-asserted-by":"crossref","unstructured":"Gladmann DD (2005) Consensus exercise on domains in psoriatic arthritis. Ann Rheum Dis [Suppl 2] 64: II113\u2013II114","DOI":"10.1136\/ard.2004.030882"},{"key":"46_CR26","unstructured":"Gladman DD, Rahman P (2001) Psoriatic arthritis. In: Ruddy S, Harris ED, Sledge CB, Budd RC, Sergent JS (eds) Textbook of rheumatology, 6th edn. Saunders, Philadelphia, pp\u00a01071\u20131079"},{"key":"46_CR27","first-page":"127","volume":"62","author":"Gladman","year":"1987","unstructured":"Gladman DD, Shuckett R, Russel ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis \u2014 clinical and laboratory analysis of 220 patients. Q J Med 62: 127\u2013141","journal-title":"Q J Med"},{"key":"46_CR28","first-page":"62","volume":"17","author":"Gladman","year":"1990","unstructured":"Gladman D, Farewell V, Buskila D (1990) Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 17: 62\u201364","journal-title":"J Rheumatol"},{"key":"46_CR29","first-page":"371","volume":"15","author":"Gladman","year":"1992","unstructured":"Gladman DD, Brubacher B, Buskila D, Langevits P, Farewell VT (1992) Psoriatic spondylarthropathy in men and women: a clinical, radiographic, and HLA study. Clin Invest Med 15: 371\u2013375","journal-title":"Clin Invest Med"},{"key":"46_CR30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","volume":"41","author":"Gladman","year":"1998","unstructured":"Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41: 1103\u20131110","journal-title":"Arthritis Rheum"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/art.11417","volume":"50","author":"Gladman","year":"2004","unstructured":"Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W (2004) Assessment of patients with psoriatic arthritis. A review of currently available measures. Arthritis Rheum 50: 24\u201335","journal-title":"Arthritis Rheum"},{"key":"46_CR32","doi-asserted-by":"crossref","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis [Suppl II] 64: II14\u2013II17","DOI":"10.1136\/ard.2004.032482"},{"key":"46_CR33","first-page":"2262","volume":"32","author":"Gladman","year":"2005","unstructured":"Gladman DD, Mease PJ, Krueger G et al. (2005) Outcome measures in psoriatic arthritis. J Rheumatol 32: 2262\u20132269","journal-title":"J Rheumatol"},{"key":"46_CR34","unstructured":"Gladman D, Strand V, Mease P, Antoni C, Nash P, Kavanaugh A (in press) OMERACT psoriatic arthritis workshop. J Rheumatol in press"},{"key":"46_CR35","first-page":"1745","volume":"32","author":"Helliwell","year":"2005","unstructured":"Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE (2005) Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 32: 1745\u20131750","journal-title":"J Rheumatol"},{"key":"46_CR36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"Henseler","year":"1985","unstructured":"Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13: 450\u2013456","journal-title":"J Am Acad Dermatol"},{"key":"46_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.62.2.127","volume":"62","author":"Heuft-Dorenbosch","year":"2003","unstructured":"Heuft-Dorenbosch L, Spoorenberg A, Van Tubergen A et al. (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62: 127\u2013132","journal-title":"Ann Rheum Dis"},{"key":"46_CR38","first-page":"2146","volume":"25","author":"Husted","year":"1998","unstructured":"Husted JA, Gladman DD, Cook RJ, Farewell VJ (1998) Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol 25: 2146\u20132155","journal-title":"J Rheumatol"},{"key":"46_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","volume":"45","author":"Husted","year":"2001","unstructured":"Husted JA, Gladman DD, Farewell VT, Cook R (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Care Res 45: 151\u20138","journal-title":"Arthritis Care Res"},{"key":"46_CR40","first-page":"1694","volume":"21","author":"Jenkinson","year":"1994","unstructured":"Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21: 1694\u20131698","journal-title":"J Rheumatol"},{"key":"46_CR41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0950-3579(94)80022-7","volume":"8","author":"Kahn","year":"1994","unstructured":"Kahn MF, Khan MA (1994) The SAPHO syndrome. Baillieres Clin Rheumatol 8: 333\u2013362","journal-title":"Baillieres Clin Rheumatol"},{"key":"46_CR42","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","volume":"50","author":"Kaltwasser","year":"2004","unstructured":"Kaltwasser JP, Nash P, Gladman D et al. for the TOPAS Study Group (2004) Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis. Arthritis Rheum 50: 1939\u20131950","journal-title":"Arthritis Rheum"},{"key":"46_CR43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/art.11416","volume":"49","author":"Katz","year":"2003","unstructured":"Katz PP (2003) Introduction to special patient outcomes in rheumatology. Arthritis Care Res 49: S1\u20134","journal-title":"Arthritis Care Res"},{"key":"46_CR44","unstructured":"Kavanaugh A, Cassell S (2005) The assessment of disease activity and outcomes in psoriatic arthritis. Clin Exp Rheumatol [Suppl 39] 23: S142\u2013S147"},{"key":"46_CR45","first-page":"I","volume":"35","author":"Kohlmann","year":"1996","unstructured":"Kohlmann T, Raspe H (1996) Hannover functional questionnaire in ambulatory diagnosis of functional disability caused by backache. Rehabilitation 35: I\u2013VIII","journal-title":"Rehabilitation"},{"key":"46_CR46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","volume":"51","author":"Langley","year":"2004","unstructured":"Langley RG, Ellis CN (2004) Evaluating psoriasis with psoriasis area and severity index (PASI), psoriasis global assessment (PGA) and lattice system psoriasis global assessment (LS-PGA). J Am Acad Dermatol 51: 563\u2013569","journal-title":"J Am Acad Dermatol"},{"key":"46_CR47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s003930050030","volume":"56","author":"Lautenschlager","year":"1997","unstructured":"Lautenschlager J, Mau W, Kohlmann T et al. (1997) Comparative evaluation of a German version of the health assessment questionnaire and the Hannover functional capacity questionnaire. Z Rheumatol 56: 144\u2013155","journal-title":"Z Rheumatol"},{"key":"46_CR48","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","volume":"361","author":"Lebwohl","year":"2003","unstructured":"Lebwohl M (2003) Psoriasis. Lancet 361: 1197\u20131204","journal-title":"Lancet"},{"key":"46_CR49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2133.2003.05378.x","volume":"149","author":"Mazzotti","year":"2003","unstructured":"Mazzotti E, Picardi A, Sampogna F (2003) Sensitivity of the dermatology quality of life index to clinical change in patients with psoriasis. Br J Dermatol 149: 318\u2013322","journal-title":"Br J Dermatol"},{"key":"46_CR50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(97)12004-9","volume":"352","author":"McGonagle","year":"1998","unstructured":"McGonagle D, Gibbon W, Emery P (1998) Classification of inflammatory arthritis by enthesitis. Lancet 352: 1137\u20131140","journal-title":"Lancet"},{"key":"46_CR51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","volume":"42","author":"McHugh","year":"2003","unstructured":"McHugh N, Balachrishnan C, Jones S (2003) Progression of peripheral joint disease in PsA: a 5-year prospective study. Rheumatology 42: 778\u2013783","journal-title":"Rheumatology"},{"key":"46_CR52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.2003.006296","volume":"63","author":"McKenna","year":"2004","unstructured":"McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQol: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63: 162\u2013169","journal-title":"Ann Rheum Dis"},{"key":"46_CR53","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385\u2013390","journal-title":"Lancet"},{"key":"46_CR54","unstructured":"Mease PJ, Gottlieb AB, Wanke SL et al. (2003) Sustained improvement in activities of daily living in patients with psoriatic arthritis treated with etanercept. Arthritis Rheum [Suppl] 49: S167"},{"key":"46_CR55","unstructured":"Mease P, Ganguly L, Wanke E, Yu E, Singh A (2004) How much improvement in clinical status is considered important by patients with active psoriatic arthritis applying the outcome measures in RA clinical trials OMERACT group guidelines? Ann Rheum Dis [Suppl 1] 63: 391"},{"key":"46_CR56","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","volume":"50","author":"Mease","year":"2004","unstructured":"Mease PJ, Kivitz AJ, Burch FX et al. (2004) Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 50: 2264\u20132272","journal-title":"Arthritis Rheum"},{"key":"46_CR57","doi-asserted-by":"crossref","unstructured":"Mease PJ, Antoni CE, Gladman DD, Taylor WJ (2005) Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis [Suppl 2] 64: II49\u201354","DOI":"10.1136\/ard.2004.034165"},{"key":"46_CR58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/02841850510021256","volume":"46","author":"Milosavljevic","year":"2005","unstructured":"Milosavljevic J, Lindqvist U, Elvin A (2005) Ultrasound and power Doppler evaluation of the hand and wrist in patients with psoriatic arthritis. Acta Radiol 46: 374\u2013385","journal-title":"Acta Radiol"},{"key":"46_CR59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 55\u201378","journal-title":"Semin Arthritis Rheum"},{"key":"46_CR60","doi-asserted-by":"crossref","unstructured":"Nash P, Mease PJ, Braun J, Van der Heijde D (2005) Seronegative spondyloarthropathies: to lump or split? Ann Rheum Dis [Suppl 2] 64: II9\u201313","DOI":"10.1136\/ard.2004.033654"},{"key":"46_CR61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/000155598442809","volume":"78","author":"Offidani","year":"1998","unstructured":"Offidani A, Cellini A, Valeri G, Giovagnoni A (1998) Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venereol 78: 463\u2013465","journal-title":"Acta Derm Venereol"},{"key":"46_CR62","first-page":"926","volume":"24","author":"Olivieri","year":"1997","unstructured":"Olivieri I, Barozzi L, Pierro A, De Matteis M, Padula A, Pavlica P (1997) Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol 24: 926\u2013930","journal-title":"J Rheumatol"},{"key":"46_CR63","unstructured":"Ory P, Sharp JT, Salonen D et al. (2002) Etanercept inhibits radiographic progression in patients with psoriatic arthritis. Arthritis Rheum [Suppl] 46: S196"},{"key":"46_CR64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"Prevoo","year":"1995","unstructured":"Prevoo ML, Van\u2019t Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38: 44\u201348","journal-title":"Arthritis Rheum"},{"key":"46_CR65","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/rheumatology\/37.7.760","volume":"37","author":"Rahman","year":"1998","unstructured":"Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D (1998) Radiological assessment in psoriatic arthritis. Br J Rheumatol 37: 760\u2013765","journal-title":"Br J Rheumatol"},{"key":"46_CR66","first-page":"2094","volume":"25","author":"Rau","year":"1998","unstructured":"Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A (1998) A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 25: 2094\u20132107","journal-title":"J Rheumatol"},{"key":"46_CR67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","volume":"49","author":"Rich","year":"2003","unstructured":"Rich P, Scher R (2003) Nail psoriasis severity index: a useful for evaluation of nail psoriasis. J Am Acad Dermatol 49: 206\u2013212","journal-title":"J Am Acad Dermatol"},{"key":"46_CR68","first-page":"1998","volume":"22","author":"R","year":"1995","unstructured":"R\u00fcckmann A, Ehle B, Trampisch HJ (1995) How to evaluate measuring methods in the case of non-defined external validity. J Rheumatol 22: 1998\u20132000","journal-title":"J Rheumatol"},{"key":"46_CR69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Van der Heijde D, Khan MA, Braun J, Sieper J (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63: 535\u2013543","journal-title":"Ann Rheum Dis"},{"key":"46_CR70","unstructured":"Rudwaleit M, Metter A, Listing J, Sieper J, Braun J (in press) Inflammatory back pain in ankylosing spondylitis \u2014 a reassessment of the clinical history for classification and diagnosis. Arthritis Rheum in press"},{"key":"46_CR71","first-page":"2638","volume":"30","author":"Scarpa","year":"2003","unstructured":"Scarpa R, Cosentini E, Manguso F et al. (2003) Clinical and genetic aspects of psoriatic arthritis \u201esine psoriasis\u201c. J Rheumatol 30: 2638\u20132640","journal-title":"J Rheumatol"},{"key":"46_CR72","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780140605","volume":"14","author":"Sharp","year":"1971","unstructured":"Sharp JT, Lidsky MD, Collins LC, Moreland J (1971) Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 14: 706\u2013720","journal-title":"Arthritis Rheum"},{"key":"46_CR73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.1780380106","volume":"38","author":"Smolen","year":"1995","unstructured":"Smolen JS, Breedveld FC, Eberl G et al. (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 38: 38\u201343","journal-title":"Arthritis Rheum"},{"key":"46_CR74","unstructured":"Sokka T, Pincus T (2005) Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol [Suppl 39] 23: S58\u201362"},{"key":"46_CR75","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.bor.0000129716.12154.06","volume":"16","author":"Taylor","year":"2004","unstructured":"Taylor WJ (2004) Assessment of outcome in psoriatic arthritis. Curr Opin Rheumatol 16: 350\u2013356","journal-title":"Curr Opin Rheumatol"},{"key":"46_CR76","doi-asserted-by":"crossref","unstructured":"Taylor WJ (2005) Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods. Ann Rheum Dis [Suppl 2 ] 64: II110\u2013II1102","DOI":"10.1136\/ard.2004.030874"},{"key":"46_CR77","unstructured":"Taylor W, Helliwell P, Gladman D, Mease P, Mielants H, Marchesoni A for the CASPAR investigators (2005) Preliminary results of the Caspar Study. EULAR, European League Against Rheumatism, Wien"},{"key":"46_CR78","first-page":"743","volume":"26","author":"Van","year":"1999","unstructured":"Van der Heijde D (1999) How to read radiographs according to the Sharp\/Van der Heijde method. J Rheum 26: 743\u2013745","journal-title":"J Rheum"},{"key":"46_CR79","first-page":"1036","volume":"1989","author":"Van","year":"1989","unstructured":"Van der Heijde DM, Van Riel PM, Nuver-Zwart IH, Gribnau FW, Van der Putte LBA (1989) Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989: 1036\u20131038","journal-title":"Lancet"},{"key":"46_CR80","doi-asserted-by":"crossref","unstructured":"Van der Heijde D, Braun J, Landewe R et al. (2005) Asessment in ankylosing spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis? Ann Rheum Dis [Suppl 2] 64: II108\u2013II109","DOI":"10.1136\/ard.2004.030858"},{"key":"46_CR81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/art.20852","volume":"52","author":"Van","year":"2005","unstructured":"Van der Heijde D, Dijkmans B, Geusens P et al. (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis \u2014 results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 52: 582\u2013591","journal-title":"Arthritis Rheum"},{"key":"46_CR82","first-page":"2042","volume":"32","author":"Van","year":"2005","unstructured":"Van der Heijde MMFM, Landewe RBM, Herrmann KGA et al. and the ASAS\/OMERACT MRI in AS Working Group (2005) Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7. J Rheumatol 32: 2042\u20132047","journal-title":"J Rheumatol"},{"key":"46_CR83","doi-asserted-by":"crossref","unstructured":"Van der Heijde D, Sharp J, Wassenberg S, Gladman DD (2005) Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis [Suppl II] 64: II61\u2013II64","DOI":"10.1136\/ard.2004.030809"},{"key":"46_CR84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"Van","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361\u2013368","journal-title":"Arthritis Rheum"},{"key":"46_CR85","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","volume":"50","author":"Wanders","year":"2004","unstructured":"Wanders AJ, Landewe RB, Spoorenberg A et al. (2004) What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter. Arthritis Rheum 50: 2622\u20132632","journal-title":"Arthritis Rheum"},{"key":"46_CR86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"Ware","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473\u2013483","journal-title":"Med Care"},{"key":"46_CR87","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s003930170064","volume":"60","author":"Wassenberg","year":"2001","unstructured":"Wassenberg S, Fischer-Kahle V, Herborn G, Rau R (2001) A method to score radiographic change in psoriatic arthritis. Z Rheumatol 60: 156\u2013166","journal-title":"Z Rheumatol"},{"key":"46_CR88","unstructured":"World Health Organization (2001) International classification of functioning, disability and health (ICF). WHO, Genf"},{"key":"46_CR89","doi-asserted-by":"crossref","unstructured":"Zochling J, Brandt J, Braun J (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 9 [Epub ahead of print]","DOI":"10.1093\/rheumatology\/kei047"},{"key":"46_CR90","unstructured":"Zochling J, Van der Heijde D, Burgos-Vargas R et al. (2005) ASAS\/EULAR recommenddations for the management of ankylosing spondylitis. Ann Rheum Dis [Epub ahead of print]"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0046-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0046-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0046-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:29:36Z","timestamp":1559060976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0046-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0046-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}